Publications by authors named "April Babka"

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the worldwide COVID-19 pandemic. Animal models are extremely helpful for testing vaccines and therapeutics and for dissecting the viral and host factors that contribute to disease severity and transmissibility. Here, we report the assessment and comparison of intranasal and small particle (~3 µm) aerosol SARS-CoV-2 exposure in ferrets.

View Article and Find Full Text PDF

Numerous arenaviruses have been identified throughout the Americas and a subset of these viruses cause viral hemorrhagic fever in humans. This study compared the pathology and viral RNA distribution in Hartley guinea pigs challenged with two human-disease causing New World arenaviruses, Junin virus (JUNV) or Guanarito virus (GTOV). Histopathologic analysis and RNA in situ hybridization revealed similar pathology and viral RNA distribution for both groups of animals challenged with either JUNV or GTOV on days 3, 7, 10 and 12 post exposure (PE).

View Article and Find Full Text PDF

Close contact through sexual activity has been associated with the spread of monkeypox virus (MPXV) in the ongoing, global 2022 epidemic. However, it remains unclear whether MPXV replicates in the testes or is transmitted via semen to produce an active infection. We carried out a retrospective analysis of MPXV-infected crab-eating macaque archival tissue samples from acute and convalescent phases of infection of clade I or clade II MPXV using immunostaining and RNA in situ hybridization.

View Article and Find Full Text PDF

Eastern equine encephalitis virus (EEEV) is mosquito-borne virus that produces fatal encephalitis in humans. We recently conducted a first of its kind study to investigate EEEV clinical disease course following aerosol challenge in a cynomolgus macaque model utilizing the state-of-the-art telemetry to measure critical physiological parameters. Here, we report the results of a comprehensive pathology study of NHP tissues collected at euthanasia to gain insights into EEEV pathogenesis.

View Article and Find Full Text PDF
Article Synopsis
  • Effective therapies have been created for treating acute Ebola virus disease (EVD), but the long-term effects on survivors, particularly regarding viral persistence, are still uncertain.
  • Research on rhesus macaques showed that even after treatment with monoclonal antibodies (mAb), Ebola virus (EBOV) can persist in the brain's ventricular system, leading to severe tissue damage.
  • The study emphasizes the need for monitoring potential long-term health issues in human EVD survivors, as the treated macaques experienced fatal infections confined to the brain after initial recovery.
View Article and Find Full Text PDF
Article Synopsis
  • The emergence of SARS-CoV-2 has prompted the need for small animal models that accurately represent the disease in humans to help develop medical countermeasures.
  • Researchers evaluated male and female mice genetically modified to express human ACE2 and found that they developed severe disease after exposure to SARS-CoV-2, showing symptoms like weight loss and lung injury.
  • The study revealed that female mice had better survival rates than males after infection, with significant differences in inflammatory responses, establishing this model as crucial for understanding SARS-CoV-2 pathogenesis and testing treatments.
View Article and Find Full Text PDF

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of human coronavirus disease 2019 (COVID-19), emerged in Wuhan, China in December 2019. The virus rapidly spread globally, resulting in a public-health crisis including more than one million cases and tens of thousands of deaths. Here, we describe the identification and evaluation of commercially available reagents and assays for the molecular detection of SARS-CoV-2 in infected formalin fixed paraffin embedded (FFPE) cell pellets.

View Article and Find Full Text PDF

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of human coronavirus disease 2019 (COVID-19), emerged in Wuhan, China, in December 2019. The virus rapidly spread globally, resulting in a public health crisis including almost 5 million cases and 323,256 deaths as of May 21, 2020. Here, we describe the identification and evaluation of commercially available reagents and assays for the molecular detection of SARS-CoV-2 in infected FFPE cell pellets.

View Article and Find Full Text PDF

Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes highly lethal henipavirus encephalitis in humans. Survivors develop various neurologic sequelae, including late-onset and relapsing encephalitis, several months up to several years following initial infection. However, the underlying pathology and disease mechanisms of persistent neurologic complications remain unknown.

View Article and Find Full Text PDF